Abbott and Medtronic partner to integrate CGM system with insulin devices
Abbott has entered a global partnership focusing on the integration of its advanced FreeStyle Libre continuous glucose monitoring (CGM) technology…
Immunology
-
-
MediWound reinforces wound therapy EscharEx data ahead of Phase III trial
MediWound has published Phase II trial data showing that its wound debridement therapy, EscharEx, is superior at treating venous leg…
-
SecondWave’s ultrasound therapy improves rheumatoid arthritis in pilot study
SecondWave has reported positive initial results from a pilot study investigating its wearable therapeutic ultrasound device to treat chronic and…
-
Werfen secures CE mark for antiphospholipid syndrome assays
Werfen has received CE marking for its Aptiva antiphospholipid syndrome (APS) Immunoglobulin G (IgG) and Immunoglobulin M (IgM) reagents, meaning…
-
Boomerang hits milestone in pilot study of neurostimulator implant for IBD
Boomerang Medical has completed stage two enrolment of a pilot study investigating the use of its bioelectronic technology to treat…
-
SeaStar’s selective cytopheretic device wins FDA breakthrough designation
The US Food and Drug Administration (FDA) has granted breakthrough device designation to SeaStar’s selective cytopheretic device (SCD), meaning the…
-
Koru Medical submits PMA for infusion system
Koru Medical has submitted a 510(k) premarket notification (PMA) to the US Food and Drug Administration (FDA) for its FREEDOM60…
-
Thermo Fisher agrees to acquire CorEvitas for $913m
Thermo Fisher Scientific has signed a definitive agreement for the acquisition of US-based data intelligence company CorEvitas from Audax Private Equity in…
